Quick Answer
Biofrontera Inc. reported Stockholders Equity of $10.48 million for fiscal year 2025.
Biofrontera Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $10.48M | +136.4% |
| 2024 | $4.43M | -7.5% |
| 2023 | $4.79M | -79.9% |
| 2022 | $23.88M | +110.6% |
| 2021 | $11.34M | +94.5% |
| 2020 | $5.83M | +119.3% |
| 2019 | -$30.18M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.58M | -146.7% | +44.7% |
| June 30, 2025 | -$4.67M | -142.8% | -1033.6% |
| March 31, 2025 | $500.0K | +109.2% | -88.7% |
| December 31, 2024 | $4.43M | -7.5% | -19.8% |
| September 30, 2024 | $5.53M | +432.8% | -49.3% |
| June 30, 2024 | $10.91M | +52.1% | +301.5% |
| March 31, 2024 | -$5.42M | -132.3% | -213.0% |
| December 31, 2023 | $4.79M | -79.9% | +361.8% |
- Biofrontera Inc. showed an increase of +136.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Biofrontera Inc.’s stockholders equity has grown by 134.7% (from -$30.18 million to $10.48 million).
- The most recent figure is from Biofrontera Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: